TILT Holdings Inc. (“TILT” or the “Company”) (CSE:TILT, OTCMKTS:SVVTF), a foundational technology cannabis platform comprised of assets to support brands worldwide, announced today it has reached a milestone of supporting 2,000 brands across North America between three of its subsidiaries: Jupiter Research, LLC (“Jupiter”), Baker Technologies Inc. (“Baker”) and Blackbird Logistics Corporation (“Blackbird”). The company also announced the full integration of Baker’s toolset into Blackbird’s inventory management platform and e-commerce offerings.

“Supporting 2,000 brands is a major milestone for TILT and its subsidiaries,” said Mark Scatterday, Interim CEO of TILT Holdings. “Achieving this number is a testament to TILT’s commitment to providing value to cannabis retailers through technology, hardware and software solutions. The full integration of Baker into Blackbird provides a large scale benefit to our wholesale and retail customers by providing them the tools they need to be successful in customer relations management and cannabis distribution.”


TILT’s milestone of supporting 2,000 brands across North America comes as a result of the Company’s ongoing efforts to provide the cannabis industry with comprehensive solutions through its subsidiary brands. Jupiter is a leading inhalation hardware company that produces award-winning vaporizer platforms and sells wholesale products to cannabis brands across the globe. Baker is a leading customer relationship management (“CRM”) platform for the cannabis industry that helps dispensaries grow their business and build relationships with their customers, and services dispensaries throughout the United States, Canada, Jamaica, and Puerto Rico. Blackbird provides operations and software solutions to facilitate the movement of cannabis products at each touchpoint in the supply chain for dispensaries in California and Nevada.

The complete integration of Baker’s toolset into the Blackbird platform will extend the support that both companies can provide to retailers by connecting them to consumers in a more substantial and comprehensive way. Together, these operations should help solve issues many companies have within the cannabis distribution process and bring additional expertise and knowledge to the cannabis industry.

To learn more about TILT Holdings, Inc. visit www.tiltholdings.com. For more information about Baker, visit www.trybaker.com.

About TILT

TILT Holdings serves cannabis brands worldwide through a strong network of portfolio companies committed to technological innovations that support long-term success. TILT services more than 2,000 brands and cannabis retailers across 33 states in the U.S., as well as in Canada, Israel, Mexico, South America and the European Union. As a market leader in cannabis technology and related products and services, the Company’s core assets include wholly-owned subsidiaries Jupiter, a company that focuses on the vast potential of inhalation through innovative design, development and manufacturing; Blackbird, a company that provides operations and software solutions for wholesale and retail distribution; and Baker, a CRM platform helping dispensaries grow their business. The Company also owns cannabis operations in states including Massachusetts, led by Commonwealth Alternative Care, Inc.; and in Pennsylvania, led by Standard Farms, LLC. Headquartered in Cambridge, Massachusetts, with offices throughout the U.S., and London, TILT has over 400 employees and has sales in the U.S., Canada and Europe. For more information, visit www.tiltholdings.com.

Click here to connect with TILT Holdings (CSE: TILT, OTCQB: SVVTF) for an Investor Presentation

 

Source: www.businesswire.com

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) will release its financial results for the third quarter fiscal 2021 ended December 31, 2020 before financial markets open on February 9, 2021.

Keep reading... Show less

NYSE | TSX: ACB

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000 . The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Keep reading... Show less

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the closing of its previously announced bought deal public offering (the “Offering”) of units of the Company (the “Units”) for total gross proceeds of US$137,940,000. The Company sold 13,200,000 Units at a price of US$10.45 per Unit, including 1,200,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

Each Unit is comprised of one common share of the Company (a “Common Share”) and one half of one common share purchase warrant of the Company (each full common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company (a “Warrant Share”) for a period of 36 months following the closing date of the Offering at an exercise price of US$12.60 per Warrant Share, subject to adjustment in certain events.

Keep reading... Show less

AMP German Cannabis Group Inc. (” AMP “) (CSE: XCX ), ( Frankfurt : C4T ) (ISIN: CA00176G1028) and Aphria Inc.’s (” Aphria “) (TSX: APHA ) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (” CC Pharma “), have entered into a strategic agreement (the ” Co-Promotion Agreement “) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.

The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany . In addition, AMP will organize with the support of CC Pharma, “information events” in Germany to market Aphria branded products to doctors and pharmacists.

Keep reading... Show less

HempFusion Wellness Inc. ( TSX:CBD.U ) ( FWB:8OO ) (“ HempFusion ” or the “ Company ”) is pleased to announce that it has been included in two leading cannabis & hemp-derived CBD focused exchange-traded funds (“ ETFs ”), AdvisorShares Pure US Cannabis ETF ( NYSE:MSOS ) and AdvisorShares Pure Cannabis ETF ( NYSE:YOLO ).

AdvisorShares is a leading sponsor of actively managed ETFs. Pure US Cannabis ETF (MSOS) is the only US-listed ETF dedicated solely to US cannabis exposure, with over US$616,000,000 in assets under management (“ AUM ”). Pure Cannabis ETF (YOLO) was the first US-based actively managed ETF focused on the global cannabis industry. YOLO and MSOS endeavor to achieve long-term capital growth by investing in some of the largest foreign and domestic cannabis and hemp-derived CBD companies. The two AdvisorShares ETFs have a combined AUM of over US$880,000,000 as of January 22, 2021.

Keep reading... Show less